InMed Pharmaceuticals Inc

INM

Latest QuantConomy context for INM: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

NASDAQ

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for INM. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for INM

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
corporate event material agreement	bullish	85	Jul 10, 08:05 PM	INM filed 8-K: Material Definitive Agreement, Regulation FD Disclosure - 2 material events - [very strong bullish signal]
corporate event other event	neutral	70	Jun 10, 10:05 AM	INM filed 8-K: Other Events - 1 material event - [strong neutral signal]
corporate event material agreement	bullish	100	May 19, 02:35 PM	INM filed 8-K: Material Definitive Agreement, Change in Control, Director or Officer Changes - 4 material events - [very strong bullish signal]

Market	Exchange	Source	Asset record
INM	NASDAQ	fmp	InMed Pharmaceuticals Inc.
INM	NASDAQ	alphavantage	InMed Pharmaceuticals Inc
INM	NASDAQ	alpaca	InMed Pharmaceuticals Inc. Common Shares

Buys, last 90d

Sells, last 90d

Rows

Date	Insider	Role	Type	Shares	Price	Value	Filing
Jun 30, 2026	Vivo Opportunity, LLC	Insider	purchase	545	$1.54	$839	4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.